Company profile
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

Pipeline6 assets

  • VK2735 (Subcutaneous)VK2735 / Dual GLP-1/GIP receptor agonist / Peptide / Metabolic Disorders
    Obesity
  • VK2735 (Oral)VK2735 / Dual GLP-1/GIP receptor agonist / Peptide / Metabolic Disorders
    Obesity
  • VK2809VK2809 / Thyroid hormone receptor beta (TRβ) agonist / Small molecule / Metabolic Disorders
    NASHFibrosisNAFLD
  • VK0214VK0214 / Thyroid hormone receptor beta (TRβ) agonist / Small molecule / Rare Diseases
    X-linked adrenoleukodystrophy (X-ALD)
  • Amylin Agonist (DACRAs)Dual amylin and calcitonin receptor agonist (DACRA) / Agonist / Metabolic Disorders
    ObesityMetabolic disorders
  • VK5211VK5211 / Selective androgen receptor modulator (SARM) / Small molecule / Musculoskeletal Disorders
    Hip fracture recoveryMuscle and bone disorders

Latest news9 items

All news